Establish Epidemiologic Data of H. Pylori Infection in Children and Adolescents-Using C13-UBT
NCT00155623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2005-10-20
Summary
The aims of this prospective study are: (1) to prospectively investigate the "true" prevalence rate, the acquisition and spontaneous clearance of H. pylori infection year by year in the population whose ages between seven and fifteen. (2) to explore the risk factors of transmission of H. pylori infection in Taiwan. (This information may be use as the guide for conduction of the national policy of public health and disease prevention.)
Conditions
- H. Pylori Infection
Sponsors & Collaborators
-
Department of Health, Executive Yuan, R.O.C. (Taiwan)
collaborator OTHER_GOV -
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Jyh-Chin Yang, M.D. · Department of Internal Medicine, National Taiwan University Hospital
Eligibility
- Min Age
- 6 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-02-28
- Completion
- 2003-07-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection
NCT03524833 ·Status: COMPLETED ·Phase: PHASE4
-
Intraluminal Therapy for Helicobacter Pylori Infection
NCT03124420 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication
NCT07130253 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT05332444 ·Status: RECRUITING ·Phase: PHASE4
-
Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection
NCT03521726 ·Status: COMPLETED ·Phase: PHASE4
-
Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
NCT03556254 ·Status: UNKNOWN ·Phase: PHASE4
-
Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication
NCT01725906 ·Status: UNKNOWN ·Phase: PHASE4
-
Epidemiology of Helicobacter Pylori Infection in Children From Slovenia
NCT05846061 ·Status: UNKNOWN
-
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection
NCT02934048 ·Status: UNKNOWN ·Phase: PHASE4
-
Feasibility Study to Diagnose Helicobacter Pylori in the Paediatric Population Using Non-invasive Fecal Analysis
NCT07083804 ·Status: RECRUITING
-
High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)
NCT07121205 ·Status: COMPLETED
-
Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection
NCT00854451 ·Status: COMPLETED ·Phase: PHASE4
-
PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study
NCT05681689 ·Status: RECRUITING ·Phase: PHASE3
-
The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial
NCT05586113 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
NCT02490839 ·Status: COMPLETED ·Phase: PHASE4
-
H. Pylori Screen-and-treat Study in a Population of Young Adults
NCT06275204 ·Status: RECRUITING
-
A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children
NCT03365609 ·Status: RECRUITING ·Phase: NA
-
14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection
NCT06687499 ·Status: COMPLETED ·Phase: PHASE4
-
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
NCT05276557 ·Status: RECRUITING ·Phase: PHASE3
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
NCT03565484 ·Status: UNKNOWN ·Phase: PHASE4
-
Helicobacter Pylori Resistance
NCT05019586 ·Status: COMPLETED
-
A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
NCT02689583 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of 10-day and 14-day Sequential Therapy Versus Triple Therapy on the Eradication of Helicobacter Pylori
NCT01042184 ·Status: COMPLETED ·Phase: PHASE4
-
Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication
NCT03156855 ·Status: UNKNOWN ·Phase: PHASE4